Skip to main content

Table 1 Demographic data, preoperative co-morbidities and medications stratified by the presence of DTA atheroma and IABP support.

From: Descending aortic calcification increases renal dysfunction and in-hospital mortality in cardiac surgery patients with intraaortic balloon pump counterpulsation placed perioperatively: a case control study

Group

-DTA/-IABP

(Number = 114)

-DTA/+IABP

(Number = 114)

+DTA/-IABP

(Number = 113)

+DTA/+IABP

(Number = 113)

Age in years

(Mean ± SD)

65/± 13.7

65/± 11.8

71/± 11.2

71.4/± 9.7

Male

72 (63.0%)

66 (57.6%)

61 (53.9%)

64 (56.6%)

Female

42 (36.0%)

48 (42.4%)

52 (46.0%)

49 (42.9%)

HTN

74 (62.2%)

81 (68.6%)

75 (70.8%)

87 (79.8%)

DM

32 (26.9%)

31 (26.3%)

47 (44.3%)

46 (42.2%)

HCL.

80 (67.2%)

83 (70.3%)

78 (73.6%)

82 (75.2%)

ACE

74 (62.2%)

50 (42.3%)

63 (59.4%)

64 (58.7%)

ASA

86 (72.3%)

76 (64.4%)

77 (72.6%)

86 (78.9%)

Statins

76 (63.9%)

67 (56.8%)

68 (64.1%)

67 (61.5%)

LVEF (%)

41.4/± 15.6

43.0/± 15.3

39.6/± 15.4

38.6/± 15.1

CHF

41 (34.5%)

57 (48.3%)

45 (42.5%)

64 (58.7%)

  1. ACE, angiotension converting enzyme inhibitors; ASA, aspirin; CHF, congestive heart failure; DM, diabetes mellitus; HCL, hypercholesterolemia; HTN, hypertension; LVEF, left ventricular ejection fraction; Statins, HMGCoA reductase inhibitors.